Companies / Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc.

Nasdaq: APGECIK 1974640SAN FRANCISCO, CA

Financials

Revenue—
Net income$-255.84M
Total debt—
Cash$105.57M
Diluted EPS$-4.22
Shares outstanding75.7M

Ownership

75.7M shares outstanding · as of Aug 3, 2026
2.4%Insiders
Ownership
82.2%Common Stock
Share classes
Common Stock82.18%
Common Stock17.82%
Insiders2.38%1,799,503
10%+ / strategic8.21%6,213,827
Institutions89.98%68,104,721
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Henderson Michael ThomasCEOChief Executive Officer · Director
1.52%1,152,987
Fairmount Funds Management LLCDirector
0.39%298,647
Henderson JaneChief Financial Officer
0.24%179,371
Dambkowski CarlChief Medical Officer
0.22%168,498
Fairmount Healthcare Fund II L.P.Director
——
Harwin Peter EvanDirector
——
Jones William a JrDirector
——
Kiselak TomasDirector
——

Institutional holders 224

View all →
HolderValue% of shares
BlackRock, Inc.$730.95M7.28%
VR Adviser, LLC$641.08M11.22%
Fmr LLC$620.83M10.87%
Wellington Management Group LLP$358.27M6.27%
State Street Corporation$304.98M3.04%
Vanguard Group Inc$215.71M3.78%
RTW Investments, LP$204.71M3.58%
Janus Henderson Group PLC$198.81M3.12%
Driehaus Capital Management LLC$164.83M2.89%
Fairmount Funds Management LLC$154.63M2.71%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 22, 2026Fairmount Funds Management LLC
Director
SellCommon Stock$133.53M-1.8M
-85.42%
298,647
0.39% of shares
high
Jan 7, 2026Dambkowski Carl
Executive
SellCommon Stock$1.15M-15K
-6.49%
213,449
0.28% of shares
medium
Aug 5, 2026Dambkowski Carl
Executive
SellCommon Stock$737.9K-6K
-3.16%
168,498
0.22% of shares
medium
Feb 11, 2026Henderson Michael Thomas
CEO
SellCommon Stock$723.7K-11K
-0.96%
1,181,493
1.56% of shares
medium
Jan 14, 2026Henderson Michael Thomas
CEO
SellCommon Stock$676.6K-8K
-0.70%
1,203,071
1.59% of shares
medium
Mar 11, 2026Henderson Michael Thomas
CEO
SellCommon Stock$621.3K-8K
-0.71%
1,164,624
1.54% of shares
medium
Mar 11, 2026Henderson Michael Thomas
CEO
SellCommon Stock$615.0K-8K
-0.71%
1,156,405
1.53% of shares
medium
Feb 11, 2026Henderson Michael Thomas
CEO
SellCommon Stock$481.2K-8K
-0.64%
1,173,942
1.55% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Vanguard Group IncPassive13G—2,857,824—
RTW Investments, LPPassive13G/A———
T. Rowe Price Investment Management, Inc.Passive13G—6,213,827—
Wellington Management Group LLPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
APGE——03770N101—